
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Aurobindo Pharma receives USFDA Approval for Droxidopa Capsules ".
Filed with NSE ·

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Aurobindo Pharma receives USFDA Approval for Droxidopa Capsules ".
6ix hasn’t read this filing yet.
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma